GLP-1 drugs Ozempic and Wegovy cut employee sick leave by 17%
A study by researchers at Duke University and the National Bureau of Economic Research using comprehensive Danish health and employment registers found that patients who took GLP‑1 medications such as Ozempic or Wegovy experienced 17.3 % fewer long‑term sick‑leave episodes (defined as absences longer than 30 days) compared with matched individuals not on the drugs. The authors estimate the aggregate economic benefit to be roughly 1.3 %–1.5 % of a worker’s annual income, translating to an average saving of about US $866 per employee for employers and health‑care systems. The reduction in absenteeism is linked to the known cardiovascular risk‑lowering effects of GLP‑1 agents, which lower the incidence of heart attacks and strokes that often drive prolonged illness. While the analysis is based on Danish data, the researchers note that similar gains could be realized in the United States, where “presentism” – working while ill – is common, suggesting broader policy and payroll implications.
Entities: Denmark · Duke University · Dulaglutide · Leptin · National Bureau of Economic Research · Obestatin · Ozempic (semaglutide) · Salmon protein hydrolysate · Type 2 diabetes mellitus · Wegovy (semaglutide)
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 11 SOURCES] Similar benefits could apply in the United States, where presentism is common. (Study discussion)
- [● 11 SOURCES] The study estimated an economic benefit of 1.3 %–1.5 % of a worker’s annual income per employee using GLP-1 drugs. (Duke University and National Bureau of Economic Research study)
- [● 11 SOURCES] Jonathan Zhang of Duke University is a co‑author of the study. (Author list in the study)
- [● 11 SOURCES] The analysis used comprehensive Danish health and employment registers. (Study methodology description)
- [● 11 SOURCES] Patients on GLP-1 medications had 17.3 % fewer long-term sick‑leave episodes (>30 days) than comparable persons. (Duke University and National Bureau of Economic Research study)
- [● 11 SOURCES] GLP-1 medications reduce the risk of cardiovascular events such as heart attack and stroke. (General medical literature cited in the study)
- [● 11 SOURCES] Long-term sick leave was defined as absences longer than 30 days. (Duke University and National Bureau of Economic Research study)
- [● 11 SOURCES] Average savings were estimated at about US $866 per employee for employers and health‑care systems. (Duke University and National Bureau of Economic Research study)